EU Pharma Strategy Offers Window For Regulatory Optimization

‘Very Significant’ Reforms Offer A Chance To Build On Pandemic Experiences

 
• By Dave Wallace

Attendees to Medicines for Europe’s Regulatory Affairs and Pharmacovigilance virtual conference heard that a window of opportunity to optimize the region’s regulatory landscape is now “wide open” with the advent of the new EU Pharmaceutical Strategy.

Optimization key keyboard computer
Optimizing the regulatory environment in Europe is key for the off-patent industry • Source: Shutterstock

More from Archive

More from Generics Bulletin